Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Mindray Medical said that it closed the $3.3 billion go-private deal the Chinese medical device company inked with its managers.
The $28-per-share deal means MR shares have ceased trading on the New York Stock Exchange, the Shenzhen-based company said. Read more
Stryker said that it won 510(k) clearance from the FDA for its Tritanium PL posterior lumbar cage for lumbar spinal fixation.
The Kalamazoo, Mich.-based orthopedics giant said it’s planning on a 2nd-quarter release for the device, made by its Stryker Spine division using a highly porous form of titanium designed to help bone ingrowth. Stryker also makes a hip implant with the Tritanium metal. Read more
A federal appeals court refused to reconsider its decision awarding $14 million to the inventor of a cutting balloon catheter, Dr. Banning Lary, for royalties owed by Boston Scientific.
Lary initially licensed his patents to InterVentional Technologies, which was later acquired by Boston Scientific. Lary sued in 2011 after a dispute arose about when the royalty deal was due to expire, with Boston Scientific claiming it would end in 2013 instead of 2023. Read more